All products currently listed on this site are for research purposes ONLY
Inflammatory biomarker response to GLP-1 receptor agonists versus other glucose-lowering medications in patients with type 2 diabetes: systematic review and meta-analysis
A 2021 study by Zerbinati and colleagues tested a serum with 30% 3-O-ethyl-l-ascorbic acid and 1% lactic acid significantly increased collagen production, reduced UVB-induced DNA damage, and decreased melanin on a reconstructed pigmented skin model
Exenatide, a GLP-1 analog, has healing effects on LPS-induced autism model: Inflammation, oxidative stress, gliosis, cerebral GABA, and serotonin interactions
For type 2 diabetes mellitus, tirzepatide (Mounjaro) received FDA approval in May 2022 as an adjunct to diet and exercise to improve glycemic control in adults